Critical Care

official impact factor 4.60

Letter

Patience and change: a conflict of interests?

Manoj K Saxena* and Peter JD Andrews

Author Affiliations

Department of Intensive Care, University of New South Wales, St George Hospital, Gray Street, Kogarah, NSW 2217, Australia

For all author emails, please log on.

Critical Care 2006, 10:422 doi:10.1186/cc5034

Published: 19 September 2006

First paragraph (this article has no abstract)

While we must applaud industry and the Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) investigators [1] for the tremendous effort and time expended in their multicentre, international study, caution needs to be exercised before deciding to make the intervention of activated protein C (APC) a standard of treatment [2].